// App-Quantinova.ai

P-52 : FOLFIRI or FOLFOX in second line of advanced biliary tract cancer: A retrospective analysis

Researchers

Presenter

  • M. Balarine

Principal Investigators

  • T. Felismino

  • M. Camandaroba

Medical Centers

  • A.C.Camargo Cancer Center, São Paulo, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • Adrucil injection

  • Gemcitabine

  • Irinotecan

  • Cisplatin

  • FOLFIRI

  • Oxaliplatin, 5-fluorouracil and folic acid

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved